Chemical Bank raised its position in UnitedHealth Group Inc (NYSE:UNH) by 6.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,974 shares of the healthcare conglomerate’s stock after acquiring an additional 1,075 shares during the period. Chemical Bank’s holdings in UnitedHealth Group were worth $4,229,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also recently made changes to their positions in UNH. Crewe Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Ipswich Investment Management Co. Inc. acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $40,000. OLD Second National Bank of Aurora boosted its stake in UnitedHealth Group by 70.0% in the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 70 shares in the last quarter. Contravisory Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 172.1% during the fourth quarter. Contravisory Investment Management Inc. now owns 185 shares of the healthcare conglomerate’s stock worth $46,000 after buying an additional 117 shares during the period. Finally, Evolution Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $76,000. Institutional investors own 85.80% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $245.01, for a total value of $1,225,050.00. Following the completion of the transaction, the director now owns 182,372 shares of the company’s stock, valued at $44,682,963.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 2,930 shares of UnitedHealth Group stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total transaction of $742,432.70. Following the completion of the transaction, the director now directly owns 64,726 shares of the company’s stock, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 27,930 shares of company stock valued at $7,208,783. 0.87% of the stock is currently owned by corporate insiders.
Shares of UnitedHealth Group stock opened at $251.40 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group Inc has a 1 year low of $212.49 and a 1 year high of $287.94. The firm has a market cap of $243.06 billion, a P/E ratio of 19.52, a price-to-earnings-growth ratio of 1.26 and a beta of 0.79.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.20 by $0.08. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. The firm had revenue of $58.42 billion during the quarter, compared to analysts’ expectations of $58.01 billion. During the same quarter last year, the company posted $2.59 earnings per share. The firm’s revenue was up 12.2% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Inc will post 14.62 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 19th. Investors of record on Monday, March 11th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Friday, March 8th. This represents a $3.60 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 27.95%.
Several equities research analysts have recently commented on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $305.00 price objective for the company in a research note on Friday, December 14th. BMO Capital Markets set a $310.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, November 27th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Raymond James set a $310.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Wednesday, November 28th. Finally, Piper Jaffray Companies lifted their price objective on shares of UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 28th. Two analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $297.80.
TRADEMARK VIOLATION WARNING: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2019/03/17/unitedhealth-group-inc-unh-holdings-raised-by-chemical-bank.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What are defining characteristics of a correction?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.